Trial · NCT03142451
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Count at Week 12 | FMX103 1.5% | 17.56 | Standard Error 0.442 | Lesions | |
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Count at Week 12 | Vehicle Foam | 15.34 | Standard Error 0.604 | Lesions | |
| Percentage of Participants Achieving Investigator Global Assessments (IGA) Treatment Success at Week 12 | FMX103 1.5% | 52.1 | Percentage of participants | ||
| Percentage of Participants Achieving Investigator Global Assessments (IGA) Treatment Success at Week 12 | Vehicle Foam | 43.0 | Percentage of participants | ||
| Percentage of Participants Achieving IGA Treatment Success of at Least 2 Grades at Week 12 | FMX103 1.5% | 55.3 | Percentage of participants | ||
| Percentage of Participants Achieving IGA Treatment Success of at Least 2 Grades at Week 12 | Vehicle Foam | 45.8 | Percentage of participants | ||
| The Percent Change From Day 0/Baseline in Inflammatory Lesion Count at Week 12 | FMX103 1.5% | 64.13 | Standard Error 1.584 | Percent change | |
| The Percent Change From Day 0/Baseline in Inflammatory Lesion Count at Week 12 | Vehicle Foam | 56.52 | Standard Error 2.133 | Percent change | |
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Counts at Week 4 and Week 8 | FMX103 1.5% | Week 4 | 11.24 | Standard Error 0.441 | Lesions |
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Counts at Week 4 and Week 8 | Vehicle Foam | Week 4 | 8.62 | Standard Error 0.608 | Lesions |
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Counts at Week 4 and Week 8 | FMX103 1.5% | Week 8 | 15.59 | Standard Error 0.445 | Lesions |
| The Absolute Change From Day 0/Baseline in the Inflammatory Lesion Counts at Week 4 and Week 8 | Vehicle Foam | Week 8 | 12.51 | Standard Error 0.610 | Lesions |
| Percentage of Participants Achieving IGA Treatment Success at Week 4 and Week 8 | FMX103 1.5% | Week 4 | 15.3 | Percentage of participants | |
| Percentage of Participants Achieving IGA Treatment Success at Week 4 and Week 8 | Vehicle Foam | Week 4 | 9.1 | Percentage of participants | |
| Percentage of Participants Achieving IGA Treatment Success at Week 4 and Week 8 | FMX103 1.5% | Week 8 | 35.2 | Percentage of participants | |
| Percentage of Participants Achieving IGA Treatment Success at Week 4 and Week 8 | Vehicle Foam | Week 8 | 29.4 | Percentage of participants | |
| Number of Participants With Adverse Events (AEs) | FMX103 1.5% | All AEs | 98 | Participants | |
| Number of Participants With Adverse Events (AEs) | Vehicle Foam | All AEs | 58 | Participants | |
| Number of Participants With Adverse Events (AEs) | FMX103 1.5% | TEAEs | 91 | Participants | |
| Number of Participants With Adverse Events (AEs) | Vehicle Foam | TEAEs | 54 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03142451/results